Activation of the LKB1/AMPK/HIF-1α Pathway by Metformin to Promote Neovascularisation in Cerebral Ischaemia
Neurochemical Research · 2024
DOI: 10.1007/s11064-024-04235-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, 2024. Verfasst von Hongguang Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Diabetes and Angiopathy, Medicine Research Institute, Xianning Medical College, Hubei University of Science and Technology, X…. Hauptthemen laut MEDLINE: Metformin, AMP-Activated Protein Kinases, Hypoxia-Inducible Factor 1, alpha Subunit, Rats, Sprague-Dawley. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Development and utilization of experimental animal resources in Hubei Province, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
As a difficult-to-treat neurological condition, cerebral ischemia is currently limited to treatments such as intravenous recombinant tissue plasminogen activator thrombolysis and thrombectomy. Metformin, a potent antidiabetic drug, has been reported to have an independent function in enhancing the prognosis of stroke patients, in addition to its glucose-lowering effects. However, the mechanism of action of metformin in this context remains unclear. In vivo, a rat model of permanent middle cerebral artery occlusion was established, and after administration of a low dose of 10.5 mg/mL metformin, infarct area was measured by TTC staining, and cortical blood flow was determined by laser Doppler imaging. In vitro, the study established human umbilical vein endothelial cells treated with cobalt chloride. Immunofluorescence, immunohistochemistry, and Western blot experiments were performed to observe the expression of angiogenic factors, tight junction proteins, and apoptotic factors. A TUNEL assay was utilized to appraise cell death by apoptosis. A tube formation assay and scratch assay were conducted to determine the endothelial neovascularization status. Animal experiments have revealed that the administration of the AMPK activator metformin significantly reduced the infarct area, promoted the expression of angiogenic factors, and maintained the stability of tight junction proteins in endothelial cells. Moreover, metformin reduces nerve cells apoptosis by affecting the expression of the apoptotic protein cleaved-caspase3 via the HIF-1α pathway. In vitro, the LKB1/AMPK signaling pathway is activated after hypoxic stimulation, attaining its peak within the early stages of hypoxia (1-12 h) and gradually weakening thereafter. The administration of AMPK pharmacological agonists (between 36 and 48 h) can enhance AMPK activity, which can lead to the expression of angiogenic factors, maintain the stability of tight-junction proteins in endothelial cells, and facilitate endothelial cell migration and vascular structure formation. Conversely, the AMPK inhibitors exert the opposite effects. The activation of the LKB1/AMPK/HIF-1α signaling pathway by metformin in cerebral ischemia contributes to angiogenesis, promotes tissue repair in the injured area, and enhances neurologically functional symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Diabetes and Angiopathy, Medicine Research Institute, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437000, Hubei, China.
- School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, China.
- Hubei Key Laboratory of Diabetes and Angiopathy, Medicine Research Institute, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437000, Hubei, China. chenqingjie8858@163.com.
- Hubei Key Laboratory of Diabetes and Angiopathy, Medicine Research Institute, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437000, Hubei, China. tnbsys_liuchao@126.com.
- Hubei Key Laboratory of Diabetes and Angiopathy, Medicine Research Institute, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437000, Hubei, China. qingyao@hbust.edu.cn.
Förderung
- National Natural Science Foundation of China
- Development and utilization of experimental animal resources in Hubei Province
- Natural Science Foundation of Hubei Province
- Xianning City Science and Technology Plan Project
- Hubei University of Science and Technology medical research fund
Zitieren
APA
Chen, H., Yuan, Y., Zhang, Y., Liu, X., Chen, Q., Liu, C., & Yao, Q. (2024). Activation of the LKB1/AMPK/HIF-1α Pathway by Metformin to Promote Neovascularisation in Cerebral Ischaemia. Neurochemical Research. https://doi.org/10.1007/s11064-024-04235-4
Vancouver
Chen H, Yuan Y, Zhang Y, Liu X, Chen Q, Liu C, et al. Activation of the LKB1/AMPK/HIF-1α Pathway by Metformin to Promote Neovascularisation in Cerebral Ischaemia. Neurochemical Research. 2024. doi:10.1007/s11064-024-04235-4
BibTeX
@article{Chen2024,
author = {Chen, Hongguang and Yuan, Yuting and Zhang, Yue and Liu, Xiufen and Chen, Qingjie and Liu, Chao and Yao, Qing},
title = {Activation of the LKB1/AMPK/HIF-1α Pathway by Metformin to Promote Neovascularisation in Cerebral Ischaemia},
journal = {Neurochemical Research},
year = {2024},
doi = {10.1007/s11064-024-04235-4}
}
EUVIMED